McDonald GB - Search Results

1

Management of hepatic sinusoidal obstruction syndrome following treatment with gemtuzumab ozogamicin (Mylotarg).

McDonald GB. McDonald GB. Clin Lymphoma. 2002 Mar;2 Suppl 1:S35-9. doi: 10.3816/clm.2002.s.007. Clin Lymphoma. 2002. PMID: 11970769 Review.

2

Incidence of sinusoidal obstruction syndrome following Mylotarg (gemtuzumab ozogamicin): a prospective observational study of 482 patients in routine clinical practice.

Tallman MS, McDonald GB, DeLeve LD, Baer MR, Cook MN, Graepel GJ, Kollmer C. Tallman MS, et al. Among authors: mcdonald gb. Int J Hematol. 2013 Apr;97(4):456-64. doi: 10.1007/s12185-013-1275-2. Epub 2013 Mar 5. Int J Hematol. 2013. PMID: 23460018

3

Liver Complications Following Treatment of Hematologic Malignancy With Anti-CD22-Calicheamicin (Inotuzumab Ozogamicin).

McDonald GB, Freston JW, Boyer JL, DeLeve LD. McDonald GB, et al. Hepatology. 2019 Feb;69(2):831-844. doi: 10.1002/hep.30222. Epub 2019 Jan 18. Hepatology. 2019. PMID: 30120894 Free PMC article. Clinical Trial.

4

Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease).

DeLeve LD, Shulman HM, McDonald GB. DeLeve LD, et al. Among authors: mcdonald gb. Semin Liver Dis. 2002 Feb;22(1):27-42. doi: 10.1055/s-2002-23204. Semin Liver Dis. 2002. PMID: 11928077 Review.

5

Hepatic veno-occlusive disease following sirolimus-based immune suppression.

Khimani F, McDonald GB, Shulman HM, Betts B, Locke F, Fernandez H, Anasetti C, Pidala J. Khimani F, et al. Among authors: mcdonald gb. Bone Marrow Transplant. 2019 Jan;54(1):85-89. doi: 10.1038/s41409-018-0233-2. Epub 2018 Jun 12. Bone Marrow Transplant. 2019. PMID: 29895929 Clinical Trial.

6

Advances in prevention and treatment of hepatic disorders following hematopoietic cell transplantation.

McDonald GB. McDonald GB. Best Pract Res Clin Haematol. 2006;19(2):341-52. doi: 10.1016/j.beha.2005.11.008. Best Pract Res Clin Haematol. 2006. PMID: 16516132 Review.

7

Metabolism-based cyclophosphamide dosing for hematopoietic cell transplant.

McDonald GB, McCune JS, Batchelder A, Cole S, Phillips B, Ren AG, Vicini P, Witherspoon R, Kalhorn TF, Slattery JT. McDonald GB, et al. Clin Pharmacol Ther. 2005 Sep;78(3):298-308. doi: 10.1016/j.clpt.2005.05.005. Clin Pharmacol Ther. 2005. PMID: 16153400

8

Hepatobiliary complications of hematopoietic cell transplantation, 40 years on.

McDonald GB. McDonald GB. Hepatology. 2010 Apr;51(4):1450-60. doi: 10.1002/hep.23533. Hepatology. 2010. PMID: 20373370 Free PMC article. Review.

9

Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients.

Hogan WJ, Maris M, Storer B, Sandmaier BM, Maloney DG, Schoch HG, Woolfrey AE, Shulman HM, Storb R, McDonald GB. Hogan WJ, et al. Among authors: mcdonald gb. Blood. 2004 Jan 1;103(1):78-84. doi: 10.1182/blood-2003-04-1311. Epub 2003 Sep 11. Blood. 2004. PMID: 12969980

10

Sinusoidal obstruction syndrome following CD33-targeted therapy in acute myeloid leukemia.

Godwin CD, McDonald GB, Walter RB. Godwin CD, et al. Among authors: mcdonald gb. Blood. 2017 Apr 20;129(16):2330-2332. doi: 10.1182/blood-2017-01-762419. Epub 2017 Feb 2. Blood. 2017. PMID: 28153826 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results